SCI-EXPANDED 收录 He, C; Ali, DJ; Qi, YH; Li, YM; Sun, BC; Liu, R; Sun, B; Xiao, ZD. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. JOURNAL OF NANOBIOTECHNOLOGY, 2023. (UT:WOS:000992637700001)

Scopus 收录 He, C.; Jaffar Ali, D.; Qi, Y.; Li, Y.; Sun, B.; Liu, R.; Sun, B.; Xiao, Z.. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. Journal of Nanobiotechnology, 2023. (UT:SCOPUS_ID:85159772388)

EI-Compendex 收录 He, Cong; Jaffar Ali, Doulathunnisa; Qi, Yuhua; Li, Yumin; Sun, Beicheng; Liu, Rui; Sun, Bo; Xiao, Zhongdang. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells    (Open Access). Journal of Nanobiotechnology, 2023. (UT:20232214148501)

Scopus 收录 He, C.; Ali, D.J.; Sun, B.; Sun, B.-C.; Xiao, Z.-D.. Microvesicles: the functional mediators in sorafenib resistance. Cancer Drug Resistance, 2022. (UT:SCOPUS_ID:85133634614)

SCI-EXPANDED 收录 He, C; Ali, DJ; Aseervatham, GSB; Sun, B; Xiao, ZD. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. PHARMACOLOGICAL RESEARCH, 2021. (UT:WOS:000663005100008)

Scopus 收录 He, C.; Jaffar Ali, D.; Aseervatham G, S.B.; Sun, B.; Xiao, Z.. Microvesicles – promising tiny players’ of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacological Research, 2021. (UT:SCOPUS_ID:85105087737)

Scopus 收录 Jaffar Ali, D.; He, C.; Xu, H.; Kumaravel, S.; Sun, B.; Zhou, Y.; Liu, R.; Xiao, Z.. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. Life Sciences, 2021. (UT:SCOPUS_ID:85100653531)

SCI-EXPANDED 收录 Ali, DJ; He, C; Xu, HT; Kumaravel, S; Sun, B; Zhou, YT; Liu, R; Xiao, ZD. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. LIFE SCIENCES, 2021. (UT:WOS:000626600400011)

Scopus 收录 He, C.; Ali, D.J.; Li, Y.; Zhu, Y.; Sun, B.; Xiao, Z.. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells. PeerJ, 2020. (UT:SCOPUS_ID:85090604873)

SCI-EXPANDED 收录 He, C; Ali, DJ; Li, YM; Zhu, YL; Sun, B; Xiao, ZD. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells. PEERJ, 2020. (UT:WOS:000550059600004)

Scopus 收录 He, C.; Jaffar Ali, D.; Xu, H.; Kumaravel, S.; Si, K.; Li, Y.; Sun, B.; Ma, J.; Xiao, Z.. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. Experimental Cell Research, 2020. (UT:SCOPUS_ID:85084394058)

SCI-EXPANDED 收录 He, C; Ali, DJ; Xu, HT; Kumaravel, S; Si, K; Li, YM; Sun, B; Ma, JQ; Xiao, ZD. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. EXPERIMENTAL CELL RESEARCH, 2020. (UT:WOS:000537014600010)

SSCI 引用 Ali, DJ; He, C; Xu, HT; Kumaravel, S; Sun, B; Zhou, YT; Liu, R; Xiao, ZD. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. LIFE SCIENCES, 2021. (UT:WOS:000626600400011) 总引 0 他引 0

CPCI-S 引用 Ali, DJ; He, C; Xu, HT; Kumaravel, S; Sun, B; Zhou, YT; Liu, R; Xiao, ZD. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. LIFE SCIENCES, 2021. (UT:WOS:000626600400011) 总引 0 他引 0

SSCI 引用 He, C; Ali, DJ; Aseervatham, GSB; Sun, B; Xiao, ZD. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. PHARMACOLOGICAL RESEARCH, 2021. (UT:WOS:000663005100008) 总引 0 他引 0

CPCI-S 引用 He, C; Ali, DJ; Aseervatham, GSB; Sun, B; Xiao, ZD. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. PHARMACOLOGICAL RESEARCH, 2021. (UT:WOS:000663005100008) 总引 0 他引 0

SSCI 引用 He, C; Ali, DJ; Li, YM; Zhu, YL; Sun, B; Xiao, ZD. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells. PEERJ, 2020. (UT:WOS:000550059600004) 总引 0 他引 0

CPCI-S 引用 He, C; Ali, DJ; Li, YM; Zhu, YL; Sun, B; Xiao, ZD. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells. PEERJ, 2020. (UT:WOS:000550059600004) 总引 0 他引 0

SSCI 引用 He, C; Ali, DJ; Qi, YH; Li, YM; Sun, BC; Liu, R; Sun, B; Xiao, ZD. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. JOURNAL OF NANOBIOTECHNOLOGY, 2023. (UT:WOS:000992637700001) 总引 0 他引 0

CPCI-S 引用 He, C; Ali, DJ; Qi, YH; Li, YM; Sun, BC; Liu, R; Sun, B; Xiao, ZD. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. JOURNAL OF NANOBIOTECHNOLOGY, 2023. (UT:WOS:000992637700001) 总引 0 他引 0

SSCI 引用 He, C; Ali, DJ; Xu, HT; Kumaravel, S; Si, K; Li, YM; Sun, B; Ma, JQ; Xiao, ZD. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. EXPERIMENTAL CELL RESEARCH, 2020. (UT:WOS:000537014600010) 总引 0 他引 0

CPCI-S 引用 He, C; Ali, DJ; Xu, HT; Kumaravel, S; Si, K; Li, YM; Sun, B; Ma, JQ; Xiao, ZD. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. EXPERIMENTAL CELL RESEARCH, 2020. (UT:WOS:000537014600010) 总引 0 他引 0

SCI-EXPANDED 引用 He, C; Ali, DJ; Qi, YH; Li, YM; Sun, BC; Liu, R; Sun, B; Xiao, ZD. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells. JOURNAL OF NANOBIOTECHNOLOGY, 2023. (UT:WOS:000992637700001) 总引 3 他引 3

SCI-EXPANDED 引用 He, C; Ali, DJ; Aseervatham, GSB; Sun, B; Xiao, ZD. Microvesicles - promising tiny players' of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. PHARMACOLOGICAL RESEARCH, 2021. (UT:WOS:000663005100008) 总引 3 他引 3

SCI-EXPANDED 引用 Ali, DJ; He, C; Xu, HT; Kumaravel, S; Sun, B; Zhou, YT; Liu, R; Xiao, ZD. Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression. LIFE SCIENCES, 2021. (UT:WOS:000626600400011) 总引 6 他引 6

SCI-EXPANDED 引用 He, C; Ali, DJ; Li, YM; Zhu, YL; Sun, B; Xiao, ZD. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells. PEERJ, 2020. (UT:WOS:000550059600004) 总引 6 他引 5

SCI-EXPANDED 引用 He, C; Ali, DJ; Xu, HT; Kumaravel, S; Si, K; Li, YM; Sun, B; Ma, JQ; Xiao, ZD. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib. EXPERIMENTAL CELL RESEARCH, 2020. (UT:WOS:000537014600010) 总引 22 他引 20